Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer
Clinical trial NCT04728724 · RECRUITING
Trial details
- NCT number
- NCT04728724
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-10
- Primary completion
- 2023-09-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.